Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes
NY Times
JANUARY 21, 2021
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Immunization Nursing Homes Vaccines 
105 
Drug Prevents Coronavirus Infection in Nursing Homes, Maker Claims
NY Times
JANUARY 21, 2021
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
F.D.A. Clears Moderna's Covid Vaccine
NY Times
DECEMBER 18, 2020
The Food and Drug Administration authorized a second coronavirus vaccine for emergency use, clearing the way for millions more Americans to be immunized next week.
Lilly’s antibody for COVID-19 protection starts nursing home trial
pharmaphorum
AUGUST 3, 2020
While the world waits an effective coronavirus vaccine, Eli Lilly has started late-stage human testing an antibody drug as an alternative way to prevent viral transmission in high-risk locations. The post Lilly’s antibody for COVID-19 protection starts nursing home trial appeared first on.
The Use of Antipsychotic Drugs in Nursing Homes
NY Times
SEPTEMBER 16, 2021
A professor, a psychiatrist and a nurse react to a Times investigation. Also: A modern Civil War; a more confident child.
Coronavirus pharma news roundup – 07/08/20
pharmaphorum
AUGUST 7, 2020
The US government has selected a potential vaccine from Sanofi and GlaxoSmithKline for its Operation Warp Speed COVID-19 vaccine development initiative, committing up to $2.1 Gillead lost $3.3bn in Q2, with the company blaming COVID-19 and its acquisition of immune-oncology company Forty Seven for the fall.
The End Is Near: Impact of the Public Health Emergency Expiration
Integra X Files
FEBRUARY 20, 2023
The COVID-19 PHE suspended various training requirements, suspended personal visit requirements for physicians and other providers, allowed telehealth visits, and made vaccines and treatments widely available. Beginning in 2024, the administration fee for COVID-19 immunizations will be in line with other Medicare Part B vaccines.
Let's personalize your content